Alicaforsen
ISIS 2302-CS27
Phase 2 small_molecule completed
Quick answer
Alicaforsen for Ulcerative Colitis is a Phase 2 program (small_molecule) at IONIS PHARMACEUTICALS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Ulcerative Colitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed